X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9691) 9691
Book Chapter (117) 117
Newspaper Article (49) 49
Newsletter (23) 23
Magazine Article (19) 19
Book / eBook (11) 11
Dissertation (5) 5
Conference Proceeding (3) 3
Publication (3) 3
Web Resource (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9036) 9036
science & technology (6677) 6677
life sciences & biomedicine (6426) 6426
male (5370) 5370
esophageal neoplasms - drug therapy (4820) 4820
female (4768) 4768
middle aged (4579) 4579
aged (4141) 4141
esophageal cancer (3761) 3761
oncology (3704) 3704
esophageal neoplasms - pathology (3542) 3542
adult (2545) 2545
cancer (2206) 2206
antineoplastic combined chemotherapy protocols - therapeutic use (1987) 1987
esophageal neoplasms - surgery (1926) 1926
carcinoma, squamous cell - drug therapy (1845) 1845
esophageal neoplasms - radiotherapy (1742) 1742
treatment outcome (1650) 1650
surgery (1635) 1635
chemotherapy (1547) 1547
combined modality therapy (1545) 1545
prognosis (1543) 1543
esophageal neoplasms - therapy (1374) 1374
carcinoma, squamous cell - pathology (1345) 1345
esophageal neoplasms - mortality (1293) 1293
gastroenterology & hepatology (1271) 1271
care and treatment (1265) 1265
aged, 80 and over (1261) 1261
cisplatin - administration & dosage (1234) 1234
esophagus (1226) 1226
esophageal neoplasms - metabolism (1200) 1200
adenocarcinoma - drug therapy (1164) 1164
squamous cell carcinoma (1160) 1160
esophageal neoplasms - genetics (1154) 1154
fluorouracil - administration & dosage (1137) 1137
cell line, tumor (1120) 1120
neoplasm staging (1115) 1115
esophageal squamous cell carcinoma (1034) 1034
retrospective studies (984) 984
animals (955) 955
adenocarcinoma - pathology (914) 914
analysis (913) 913
abridged index medicus (895) 895
survival rate (893) 893
research (875) 875
medicine & public health (870) 870
tumors (832) 832
stomach neoplasms - drug therapy (812) 812
esophagectomy (796) 796
antineoplastic agents - therapeutic use (795) 795
carcinoma, squamous cell - radiotherapy (785) 785
metastasis (776) 776
cancer therapies (772) 772
health aspects (742) 742
carcinoma, squamous cell - surgery (722) 722
risk factors (707) 707
follow-up studies (704) 704
neoadjuvant therapy (688) 688
survival analysis (665) 665
apoptosis (652) 652
medical prognosis (642) 642
radiotherapy (634) 634
carcinoma, squamous cell - mortality (625) 625
chemotherapy, adjuvant (619) 619
carcinoma, squamous cell - metabolism (596) 596
patients (573) 573
adenocarcinoma (570) 570
antineoplastic combined chemotherapy protocols - adverse effects (566) 566
immunohistochemistry (565) 565
esophageal neoplasms - diagnosis (557) 557
mice (556) 556
carcinoma, squamous cell - genetics (554) 554
carcinoma, squamous cell - therapy (548) 548
adenocarcinoma - surgery (517) 517
disease-free survival (505) 505
development and progression (495) 495
prospective studies (495) 495
chemoradiotherapy (494) 494
gene expression (492) 492
stomach neoplasms - pathology (485) 485
drug therapy (482) 482
lymphatic metastasis (482) 482
proteins (468) 468
studies (467) 467
gene expression regulation, neoplastic (453) 453
drug administration schedule (438) 438
genetic aspects (428) 428
radiation therapy (424) 424
time factors (424) 424
radiotherapy dosage (423) 423
cell proliferation - drug effects (413) 413
apoptosis - drug effects (409) 409
adenocarcinoma - therapy (408) 408
antineoplastic agents - pharmacology (408) 408
cisplatin (408) 408
disease progression (404) 404
kaplan-meier estimate (399) 399
adenocarcinoma - mortality (396) 396
research article (396) 396
pharmacology & pharmacy (377) 377
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9060) 9060
Japanese (599) 599
French (158) 158
Chinese (156) 156
German (148) 148
Russian (75) 75
Spanish (40) 40
Italian (33) 33
Hungarian (10) 10
Korean (8) 8
Polish (8) 8
Dutch (7) 7
Portuguese (7) 7
Danish (5) 5
Hebrew (4) 4
Czech (3) 3
Croatian (2) 2
Lithuanian (2) 2
Romanian (2) 2
Swedish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European archives of oto-rhino-laryngology, ISSN 0937-4477, 1/2005, Volume 262, Issue 1, pp. 1 - 7
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 01/2018, Volume 110, Issue 1, pp. 109 - 120
Background: Cancer-associated fibroblasts (CAFs) are tumor-promoting and correlate with poor survival in many cancers, which has led to their emergence as... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Up-Regulation | Pyrazoles - therapeutic use | Reactive Oxygen Species - metabolism | Cell Count | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Head and Neck Neoplasms - chemistry | RNA Interference | Cancer-Associated Fibroblasts - chemistry | Aged, 80 and over | NADPH Oxidases - genetics | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Lung Neoplasms - chemistry | NADPH Oxidases - antagonists & inhibitors | Head and Neck Neoplasms - drug therapy | Carcinoma, Squamous Cell - chemistry | Survival Rate | Adenocarcinoma - drug therapy | Disease Progression | Phenotype | Carcinoma, Squamous Cell - drug therapy | Head and Neck Neoplasms - genetics | Mice | Neoplasm Transplantation | Carcinoma, Non-Small-Cell Lung - chemistry | Carcinoma, Squamous Cell - genetics | Colorectal Neoplasms - chemistry | Cell Transdifferentiation - genetics | Myofibroblasts - chemistry | Actins - analysis | Cell Transdifferentiation - drug effects | Adult | Female | Adenocarcinoma - genetics | Cancer-Associated Fibroblasts - physiology | Pyridines - therapeutic use | Lung Neoplasms - genetics | Myofibroblasts - pathology | Carcinoma, Non-Small-Cell Lung - genetics | NADPH Oxidases - analysis | Mouth Neoplasms - chemistry | NADPH Oxidase 4 | Cancer-Associated Fibroblasts - pathology | Animals | Esophageal Neoplasms - genetics | Mouth Neoplasms - pathology | Oropharyngeal Neoplasms - chemistry | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Colorectal Neoplasms - pathology | Esophageal Neoplasms - drug therapy | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 1 - 10
.... Results Forty-one patients with advanced solid tumours refractory to standard therapies and with adequate organ function were recruited in eight cohorts up to doses of 150... 
Hematology, Oncology and Palliative Medicine | Pharmacodynamics | MEK inhibitor | Phase I | Optimal biological dose | Pharmacokinetics | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pancreatic Neoplasms - metabolism | Nausea - chemically induced | Allosteric Regulation | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Fatigue - chemically induced | Ribosomal Protein S6 Kinases, 70-kDa - drug effects | Protein Kinase Inhibitors - adverse effects | Colorectal Neoplasms - drug therapy | Chromatography, Liquid | Proto-Oncogene Proteins c-akt - metabolism | MAP Kinase Kinase 1 - antagonists & inhibitors | Bile Duct Neoplasms - metabolism | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Administration, Oral | Carcinoma, Non-Small-Cell Lung - metabolism | Neoplasms - drug therapy | Maximum Tolerated Dose | Mesothelioma - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Anorexia - chemically induced | Glycogen Synthase Kinase 3 beta - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Neoplasms - metabolism | Phosphoproteins - drug effects | Mitogen-Activated Protein Kinase 1 - drug effects | Cholangiocarcinoma - metabolism | Chromatography, High Pressure Liquid | Diarrhea - chemically induced | Mitogen-Activated Protein Kinase 3 - drug effects | Pancreatic Neoplasms - drug therapy | Tandem Mass Spectrometry | Uterine Cervical Neoplasms - metabolism | Esophageal Neoplasms - metabolism | Adult | Female | Colorectal Neoplasms - metabolism | Bile Duct Neoplasms - drug therapy | Drug Eruptions - etiology | Abdominal Pain - chemically induced | Uterine Cervical Neoplasms - drug therapy | Glycogen Synthase Kinase 3 beta - metabolism | Mesothelioma - drug therapy | Cholangiocarcinoma - drug therapy | MAP Kinase Kinase 2 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Esophageal Neoplasms - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Care and treatment | Protein kinases | Mitogens | Cells | Tumors | Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2010, Volume 102, Issue 1, pp. 220 - 226
Journal Article
Nature medicine, ISSN 1546-170X, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin... 
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin | Index Medicus
Journal Article